Morgan Stanley Bioventus Inc. Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Bioventus Inc. stock. As of the latest transaction made, Morgan Stanley holds 445,047 shares of BVS stock, worth $2.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

445,047

Previous 193,529 129.96%

Holding current value

$2.56 Million

Previous $1.02 Million 127.09%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.33 - $5.75 $1.09 Million - $1.45 Million	251,518 Added 129.96%	445,047 $2.31 Million
Q4 2023 Feb 13, 2024	BUY	$2.89 - $5.34 $528,508 - $976,552	182,875 Added 1716.49%	193,529 $1.02 Million
Q3 2023 Nov 15, 2023	SELL	$2.8 - $4.94 $22,570 - $39,821	-8,061 Reduced 43.07%	10,654 $35,000
Q2 2023 Aug 14, 2023	SELL	$0.93 - $3.64 $47,660 - $186,542	-51,248 Reduced 73.25%	18,715 $54,000
Q1 2023 May 15, 2023	SELL	$1.07 - $2.95 $50,428 - $139,030	-47,129 Reduced 40.25%	69,963 $74,000

Q4 2022 Feb 14, 2023	BUY	$1.81 - $8.14 $141,990 - $638,566	78,448 Added 203.0%	117,092 $305,000
Q3 2022 Nov 14, 2022	BUY	$6.54 - $9.08 $183 - $254	28 Added 0.07%	38,644 $272,000
Q2 2022 Oct 27, 2022	BUY	$6.82 - $13.82 $49,342 - $99,987	7,235 Added 23.06%	38,616 $262,000
Q2 2022 Aug 15, 2022	BUY	$6.82 - $13.82 $49,342 - $99,987	7,235 Added 23.06%	38,616 $262,000
Q1 2022 Oct 27, 2022	SELL	$11.65 - $15.28 $84,287 - $110,550	-7,235 Reduced 18.74%	31,381 $443,000
Q1 2022 May 13, 2022	SELL	$11.65 - $15.28 $315,004 - $413,155	-27,039 Reduced 46.28%	31,381 $443,000
Q4 2021 Feb 14, 2022	BUY	$12.37 - $16.77 $645,342 - $874,890	52,170 Added 834.72%	58,420 $847,000
Q3 2021 Nov 15, 2021	BUY	$13.7 - $17.25 $85,625 - $107,812	6,250 New	6,250 $88,000

Others Institutions Holding BVS

# of Institutions

Shares Held

35.7M

Call Options Held

167K

Put Options Held

126K

View Full List

About Bioventus Inc.

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $355M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

More about BVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account